Sean N Tucker

Summary

Publications

  1. doi request reprint Oral adenoviral-based vaccines: historical perspective and future opportunity
    Sean N Tucker
    Vaxart, Inc, 600 Townsend St, Suite 120E, San Francisco, CA 94103, USA
    Expert Rev Vaccines 7:25-31. 2008
  2. doi request reprint Oral administration of an adenovirus vector encoding both an avian influenza A hemagglutinin and a TLR3 ligand induces antigen specific granzyme B and IFN-γ T cell responses in humans
    Wendy Peters
    Vaxart, Inc, 20 California Street, San Francisco, CA 94111, United States
    Vaccine 31:1752-8. 2013
  3. pmc An adenovirus-based vaccine with a double-stranded RNA adjuvant protects mice and ferrets against H5N1 avian influenza in oral delivery models
    Ciaran D Scallan
    Vaxart, Inc, San Francisco, CA, USA
    Clin Vaccine Immunol 20:85-94. 2013
  4. ncbi request reprint Systemic and mucosal antibody responses following retroductal gene transfer to the salivary gland
    Sean N Tucker
    Genteric, Inc, 1650 Harbor Bay Parkway, Alameda, California 94502, USA
    Mol Ther 8:392-9. 2003

Collaborators

  • Ciaran D Scallan
  • Jonathan D Lindbloom
  • Debora W Tingley
  • Wendy Peters
  • Jennifer R Brandl
  • C Josefina Martinez
  • Martin L Kabongo
  • George R Trager
  • James S Toomey

Detail Information

Publications4

  1. doi request reprint Oral adenoviral-based vaccines: historical perspective and future opportunity
    Sean N Tucker
    Vaxart, Inc, 600 Townsend St, Suite 120E, San Francisco, CA 94103, USA
    Expert Rev Vaccines 7:25-31. 2008
    ..Recent discoveries may allow this platform approach to reach the clinic within a few years...
  2. doi request reprint Oral administration of an adenovirus vector encoding both an avian influenza A hemagglutinin and a TLR3 ligand induces antigen specific granzyme B and IFN-γ T cell responses in humans
    Wendy Peters
    Vaxart, Inc, 20 California Street, San Francisco, CA 94111, United States
    Vaccine 31:1752-8. 2013
    ..To test the safety and immunogenicity of an orally delivered avian influenza vaccine. The vaccine has a non-replicating adenovirus type 5 vector backbone which expresses hemagglutinin from avian influenza and a TLR3 ligand as an adjuvant...
  3. pmc An adenovirus-based vaccine with a double-stranded RNA adjuvant protects mice and ferrets against H5N1 avian influenza in oral delivery models
    Ciaran D Scallan
    Vaxart, Inc, San Francisco, CA, USA
    Clin Vaccine Immunol 20:85-94. 2013
    ..Similarly, experiments in mice demonstrated selective immune responses against HA with peroral delivery and the ability to circumvent preexisting vector immunity...
  4. ncbi request reprint Systemic and mucosal antibody responses following retroductal gene transfer to the salivary gland
    Sean N Tucker
    Genteric, Inc, 1650 Harbor Bay Parkway, Alameda, California 94502, USA
    Mol Ther 8:392-9. 2003
    ..These data suggest that SG genetic immunization may offer advantages over conventional routes of vaccination...